Notable
ENV-294 · Moderate-to-Severe Atopic Dermatitis
Enrollment increased: 60 → 105 participants
Enveda TherapeuticsPhase 2 NCT07298395 Registry history of NCT07298395 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Enrollment increased: 60 → 105 participants
Enveda TherapeuticsPhase 2 NCT07298395 Registry history of NCT07298395 on ClinicalTrials.gov (opens the registry)
| Phase 2 | 3 |
Atopic Dermatitis (2) · Asthma (1)